NK VUE Trademark

Trademark Overview


On Wednesday, June 4, 2014, a trademark application was filed for NK VUE with the United States Patent and Trademark Office. The USPTO has given the NK VUE trademark a serial number of 86300720. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Saturday, February 4, 2023. This trademark is owned by ATGen Co., Ltd.. The NK VUE trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use

NK cell activation testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical, research or medical laboratory use; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of (monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis,...
nk vue

General Information


Serial Number86300720
Word MarkNK VUE
Filing DateWednesday, June 4, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSaturday, February 4, 2023
Registration Number4993881
Registration DateTuesday, July 5, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 18, 2015

Trademark Statements


Goods and Servicesdiagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
Pseudo MarkNK VIEW
Goods and ServicesNK cell activation testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical, research or medical laboratory use; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of (monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
Disclaimer with Predetermined Text"NK"

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, June 17, 2014
Primary Code001
First Use Anywhere DateTuesday, March 31, 2015
First Use In Commerce DateTuesday, March 31, 2015

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, June 17, 2014
Primary Code005
First Use Anywhere DateTuesday, March 31, 2015
First Use In Commerce DateTuesday, March 31, 2015

Trademark Owner History


Party NameNKMAX CO., LTD.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressSEONGNAM-SI, GYEONGGI-DO 13605
KR

Party NameATGen Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGyeonggi-do 463-400
KR

Party NameATGen Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGyeonggi-do 463-400
KR

Party NameATGen Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGyeonggi-do 463-400
KR

Trademark Events


Event DateEvent Description
Saturday, February 4, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, February 4, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Saturday, February 4, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, August 3, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, July 19, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, July 5, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 2, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 5, 2016REGISTERED-PRINCIPAL REGISTER
Thursday, June 2, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, June 1, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 17, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 13, 2016USE AMENDMENT FILED
Thursday, May 12, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 13, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, October 13, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 18, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 18, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 29, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, July 1, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 24, 2015EXAMINER'S AMENDMENT ENTERED
Monday, June 22, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 22, 2015EXAMINERS AMENDMENT E-MAILED
Monday, June 22, 2015EXAMINERS AMENDMENT -WRITTEN
Tuesday, April 14, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, April 14, 2015FINAL REFUSAL E-MAILED
Tuesday, April 14, 2015FINAL REFUSAL WRITTEN
Wednesday, March 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 18, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 17, 2015ASSIGNED TO LIE
Monday, March 9, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 22, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 22, 2014NON-FINAL ACTION E-MAILED
Monday, September 22, 2014NON-FINAL ACTION WRITTEN
Tuesday, September 16, 2014ASSIGNED TO EXAMINER
Wednesday, June 18, 2014NOTICE OF PSEUDO MARK E-MAILED
Tuesday, June 17, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 7, 2014NEW APPLICATION ENTERED